Carton (Image 01)
Reclast Injection, Solution
Product Images NDC 66758-155
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 4 technical images submitted to the FDA as part of the official labeling for Reclast (NDC 66758-155). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Sandoz Inc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Zoledronic Acid Structural Formula (Reclast 01)
Figure 1. Cumulative Incidence Of Hip Fracture Over 3 Years (Reclast 02)
This text appears to be a statistical data output showing information related to two groups labeled as "Placebo" and "Reclast". The data includes sample sizes for each group, with Placebo having 3851 participants and Reclast having 3875 participants. The data also appears to be related to the time to hip fracture in months.*
Figure 2. Therapeutic Response/serum Alkaline Phosphatase (sap) Normalization Over Time (Reclast 03)
* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.
